|
1
|
Friedman SL: Mechanisms of hepatic
fibrogenesis. Gastroenterology. 134:1655–1669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bataller R and Brenner DA: Liver fibrosis.
J Clin Invest. 115:209–218. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoshiji H, Kuriyama S, Yoshii J, Ikenaka
Y, Noguchi R, Nakatani T, Tsujinoue H and Fukui H: Angiotensin-II
type 1 receptor interaction is a major regulator for liver fibrosis
development in rats. Hepatology. 34:745–750. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Debernardi-Venon W, Martini S, Biasi F,
Vizio B, Termine A, Poli G, Brunello F, Alessandria C, Bonardi R,
Saracco G, et al: AT1 receptor antagonist Candesartan in selected
cirrhotic patients: Effect on portal pressure and liver fibrosis
markers. J Hepatol. 46:1026–1033. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Matono T, Koda M, Tokunaga S, Sugihara T,
Ueki M and Murawaki Y: The effects of the selective
mineralocorticoid receptor antagonist eplerenone on hepatic
fibrosis induced by bile duct ligation in rat. Int J Mol Med.
25:875–882. 2010.PubMed/NCBI
|
|
6
|
Noguchi R, Yoshiji H, Ikenaka Y, Kaji K,
Shirai Y, Aihara Y, Yamazaki M, Namisaki T, Kitade M, Yoshii J, et
al: Selective aldosterone blocker ameliorates the progression of
non-alcoholic steatohepatitis in rats. Int J Mol Med. 26:407–413.
2010.PubMed/NCBI
|
|
7
|
Yoshiji H, Kuriyama S, Yoshii J, Ikenaka
Y, Noguchi R, Yanase K, Namisaki T, Yamazaki M, Tsujinoue H, Imazu
H and Fukui H: Angiotensin-II induces the tissue inhibitor of
metalloproteinases-1 through the protein kinase-C signaling pathway
in rat liver fibrosis development. Hepatol Res. 27:51–56. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Horiuchi K, Amizuka N, Takeshita S,
Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF and Kudo A:
Identification and characterization of a novel protein, periostin,
with restricted expression to periosteum and periodontal ligament
and increased expression by transforming growth factor beta. J Bone
Miner Res. 14:1239–1249. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L, Fan D, Wang C, Wang JY, Cui XB, Wu
D, Zhou Y and Wu LL: Angiotensin II increases periostin expression
via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac
fibroblasts. Cardiovasc Res. 91:80–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yoshiji H, Kuriyama S, Kawata M, Yoshii J,
Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H and Fukui H: The
angiotensin-I-converting enzyme inhibitor perindopril suppresses
tumor growth and angiogenesis: Possible role of the vascular
endothelial growth factor. Clin Cancer Res. 7:1073–1078.
2001.PubMed/NCBI
|
|
11
|
Kaji K, Yoshiji H, Ikenaka Y, Noguchi R,
Aihara Y, Douhara A, Moriya K, Kawaratani H, Shirai Y, Yoshii J, et
al: Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis
via suppression of activated hepatic stellate cell in rats. J
Gastroenterol. 49:481–491. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kanda Y: Investigation of the freely
available easy-to use software ‘EZR’ for medical statics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kudo A: Periostin in fibrillogenesis for
tissue regeneration: Periostin actions inside and outside the cell.
Cell Mol Life Sci. 68:3201–3207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Snider P, Hinton RB, Moreno-Rodriguez RA,
Wang J, Rogers R, Lindsley A, Li F, Ingram DA, Menick D, Field L,
et al: Periostin is required for maturation and extracellular
matrix stabilization of noncardiomyocyte lineages of the heart.
Circ Res. 102:752–760. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brown RD, Ambler SK, Mitchell MD and Long
CS: The cardiac fibroblast: Therapeutic target in myocardial
remodeling and failure. Annu Rev Pharmacol Toxicol. 45:657–687.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Iekushi K, Taniyama Y, Azuma J, Katsuragi
N, Dosaka N, Sanada F, Koibuchi N, Nagao K, Ogihara T and Morishita
R: Novel mechanisms of valsartan on the treatment of acute
myocardial infarction through inhibition of the antiadhesion
molecule periostin. Hypertension. 49:1409–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hong L, Shejiao D, Fenrong C, Gang Z and
Lei D: Periostin down-regulation attenuates the pro-fibrogenic
response of hepatic stellate cells induced by TGF-β1. J Cell Mol
Med. 19:2462–2468. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Noguchi R, Yoshiji H, Ikenaka Y, Kaji K,
Aihara Y, Shirai Y, Namisaki T, Kitade M, Douhara A, Moriya K and
Fukui H: Dual blockade of angiotensin-II and aldosterone suppresses
the progression of a non-diabetic rat model of steatohepatitis.
Hepatol Res. 43:765–774. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bataller R, Sancho-Bru P, Gines P, Lora
JM, Al-Garawi A, Solé M, Colmenero J, Nicolás JM, Jiménez W, Weich
N, et al: Activated human hepatic stellate cells express the
renin-angiotensin system and synthesize angiotensin II.
Gastroenterology. 125:117–125. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Wu S, Xiong S and Ouyang G:
Deficiency of periostin protects mice against
methionine-choline-deficient diet-induced non-alcoholic
steatohepatitis. J Hepatol. 62:495–497. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang Y, Liu W, Xiao H, Maitikabili A, Lin
Q, Wu T, Huang Z, Nicolás JM, Jiménez W and Weich N: Matricellular
protein periostin contributes to hepatic inflammation and fibrosis.
Am J Pathol. 185:786–797. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Henderson NC, Arnold TD, Katamura Y,
Giacomini MM, Rodriguez JD, McCarty JH, Pellicoro A, Raschperger E,
Betsholtz C, Ruminski PG, et al: Targeting of αv integrin
identifies a core molecular pathway that regulates fibrosis in
several organs. Nat Med. 19:1617–1624. 2013. View Article : Google Scholar : PubMed/NCBI
|
